1. Home
  2. GMAB
  3. GMAB News

Latest Genmab A/S ADS (GMAB) News on September 12, 2025

Genmab (CPSE:GMAB) Is Up 10.3% After FDA Breakthrough for Rina-S in Endometrial Cancer – Has The Bull Case Changed?

Simply Wall St.

6 days ago

Genmab (CPSE:GMAB) Is Up 10.3% After FDA Breakthrough for Rina-S in Endometrial Cancer – Has The Bull Case Changed?

Share on Social Networks: